C07D 405/00
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms
Official title: Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D405/00 (Heterocyclic compounds containing both one or more hetero rings having oxygen atoms) appears on 22,076 US grants and 24,963 published applications in this corpus.
Search patents in C07D- Granted patents
- 22,076
- Published applications
- 24,963
- Assignees
- 5,131
- Inventors
- 48,344
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 43 | 0 |
| 1977 | 32 | 0 |
| 1978 | 34 | 0 |
| 1979 | 18 | 0 |
| 1980 | 9 | 0 |
| 1981 | 17 | 0 |
| 1982 | 17 | 0 |
| 1983 | 35 | 0 |
| 1984 | 69 | 0 |
| 1985 | 139 | 0 |
| 1986 | 133 | 0 |
| 1987 | 160 | 0 |
| 1988 | 157 | 0 |
| 1989 | 214 | 0 |
| 1990 | 265 | 0 |
| 1991 | 292 | 0 |
| 1992 | 281 | 0 |
| 1993 | 336 | 0 |
| 1994 | 268 | 0 |
| 1995 | 320 | 0 |
| 1996 | 322 | 0 |
| 1997 | 395 | 0 |
| 1998 | 373 | 0 |
| 1999 | 353 | 0 |
| 2000 | 393 | 0 |
| 2001 | 405 | 84 |
| 2002 | 485 | 422 |
| 2003 | 428 | 727 |
| 2004 | 382 | 1019 |
| 2005 | 414 | 984 |
| 2006 | 490 | 899 |
| 2007 | 526 | 928 |
| 2008 | 514 | 884 |
| 2009 | 616 | 1068 |
| 2010 | 701 | 1081 |
| 2011 | 661 | 946 |
| 2012 | 749 | 905 |
| 2013 | 886 | 982 |
| 2014 | 913 | 1121 |
| 2015 | 969 | 1187 |
| 2016 | 856 | 1138 |
| 2017 | 996 | 1089 |
| 2018 | 845 | 1037 |
| 2019 | 888 | 1105 |
| 2020 | 839 | 1162 |
| 2021 | 720 | 1027 |
| 2022 | 670 | 1032 |
| 2023 | 572 | 1291 |
| 2024 | 651 | 1166 |
| 2025 | 725 | 980 |
| 2026 | 500 | 699 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Aromatic amine derivative, and organic electroluminescent element using same6 Oct 2026US 12,753,145 B2Idemitsu Kosan Co., Ltd.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- CCR6 receptor modulators6 Oct 2026US 12,753,168 B2Idorsia Pharmaceuticals Ltd
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Antidegradant bis(dihydro and tetrahydroquinoline) compounds and uses thereof8 Oct 2026US 2026/0308127 A1Flexsys IP Holdings, LLC
- Uric acid transporter agonist compound, pharmaceutical composition, and preparation method therefor and use thereof8 Oct 2026US 2026/0308136 A1Hangzhou E & J Biopharmaceutical Technology Co., Ltd.
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
Most cited
By later US patents
- Backbone modified oligonucleotide analogs983US 5,602,240 ACiba-Geigy Corporation · 1997
- Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms772US 5,489,677 AIsis Pharmaceuticals, Inc. · 1996
- Conjugated 4'-desmethyl nucleoside analog compounds660US 5,608,046 AIsis Pharmaceuticals, Inc. · 1997
- Pyrimidine derivatives for labeled binding partners639US 5,502,177 AGilead Sciences, Inc. · 1996
- Backbone modified oligonucleotide analogues637US 5,610,289 AIsis Pharmaceuticals, Inc. · 1997